Emixustat
CAS: 1141777-14-1
Ref. 3D-FE171071
1mg | 213.00 € | ||
2mg | 340.00 € | ||
5mg | 479.00 € | ||
10mg | 569.00 € | ||
25mg | 1,016.00 € |
Product Information
- (aR)-a-(2-Aminoethyl)-3-(cyclohexylmethoxy)benzenemethanol
Emixustat is a chemical inhibitor that inhibits the activity of the cation channel TRPM1. TRPM1 is expressed in choroidal neovascularization and proliferative diabetic retinopathy. It also has shown potential as a diagnostic agent for these eye disorders. Emixustat has been shown to inhibit the production of growth factors, which may be a cause for its therapeutic effect in both congenital amaurosis and growth factor-related eye disorders. Emixustat is an investigational drug that has not been approved by the FDA yet, but it is currently in phase III clinical trials.
Chemical properties
Technical inquiry about: 3D-FE171071 Emixustat
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.